You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股》恆指收跌153點 比亞迪電子吐近5% 黃金及金飾股造好
投資者關注債息上升,港股先升後跌,恆指高開164點,初段升293點見25,789點後回落,午後曾跌219點一度低見25,276點,全日跌153點或0.6%,收25,343點;國指跌58點或0.6%,收9,050點;恆生科技指數跌44點或0.8%,收5,683點。大市全日成交總額2,676.47億元。 科技股方面,阿里(09988.HK)、騰訊(00700.HK)及美團(03690.HK)跌0.3%至0.6%,中芯(00981.HK)、小米(01810.HK)、網易(09999.HK)及嗶哩嗶哩(09626.HK)跌1.2%至2.1%,京東(09618.HK)及快手(01024.HK)升不足1%,百度(09888.HK)升2.8%。醫療平臺平安好醫生(01833.HK)及阿里健康(00241.HK)升10.3%及4.6%,手機相關股比亞迪電子(00285.HK)回吐5%。 宇樹科技預告今年內提交IPO申請,在港上市機器人概念股優必選(09880.HK)及越疆(02432.HK)倒跌2%及2.1%。首程控股(00697.HK)升6%,該公司旗下基金投資宇樹科技。 蔚來(09866.HK)季度經調整淨虧損按年收窄9%,公司第四季目標每月交付量達5萬輛,股價升1%。比亞迪(01211.HK)及小鵬(09868.HK)跌2.5%及2.2%。汽車代理中升(00881.HK)獲瑞銀上調評級至「買入」,股價升3.1%。藥明合聯(02268.HK)折讓4%配股淨籌13億元,股價升9.3%。同系藥明生物(02269.HK)升2.4%。其他醫藥股方面,恆瑞醫藥(01276.HK)升8.3%,諾誠健華(09969.HK)及石藥(01093.HK)升6.7%及4.5%,康希諾(06185.HK)升4.2%。消費股方面,潤啤(00291.HK)及海信家電(00921.HK)跌3.4%及5.1%,中國旺旺(00151.HK)升3.1%。 金融股方面,匯控(00005.HK)、港交所(00388.HK)及友邦(01299.HK)跌0.6%至1.4%,富衛(01828.HK)升3.2%。中國平安(02318.HK)增持國壽(02628.HK)4,409.5萬股,中國平安升0.1%,國壽跌0.8%。衆安在線(06060.HK)跌3.7%。內地股市回吐,券商股中金(03908.HK)跌3.3%。 期金升穿3,600美元水平,靈寶(03330.HK)及招金(01818.HK)升6.1%及4%,紫金(02899.HK)及山東黃金(01787.HK)升1.8%及2.1%。江銅(00358.HK)亦升4.7%。金飾零售股六福(00590.HK)、周大福(01929.HK)及周生生(00116.HK)升2.4%至4.1%,老鋪黃金(06181.HK)升0.5%。 長飛光纖光纜(06869.HK)炒高12.8%,成交逾28億元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account